KLOW

Description

KLOW is BioRhex’s proprietary recovery research blend combining four complementary peptides in a single compound: BPC-157 (gastric-derived pentadecapeptide), TB-500 (Thymosin Beta-4 active fragment), KPV (alpha-MSH C-terminal tripeptide), and GHK-Cu (copper-binding tripeptide). In research settings, KLOW is studied as a multi-pathway approach to tissue repair signaling, inflammatory modulation, and cellular recovery mechanism research.

BioRhex supplies KLOW as a research compound manufactured in a GMP-compliant US facility, tested to ≥99% purity via HPLC and mass spectrometry, and supplied strictly for controlled laboratory research — not for human or animal use.